ACE and coronary artery disorder: An angiotensin-converting enzyme (ACE) inhibitor was also absent for 422 patients who had systolic heart failure and/or documented coronary artery disease (N = 618; 68% 95% CI 65–72) (Supplementary START version 2 Table).